Benlysta Treatment Lowers Disease Activity for SLE Patients, Real-world Data Shows
News
Treatment with Benlysta (belimumab) induces meaningful and long-lasting reductions in systemic lupus erythematosus (SLE) disease activity, helping a significant proportion of ... Read more